KRISTIN HAAG: Open Payments
NPI 1790267524 · SHELBYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 21 payments from 11 companies in 2025. Trend: 2023 $1,251 · 2024 $1,341 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $84 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| PFIZER INC. | 3 | $50 |
| Novo Nordisk Inc | 3 | $49 |
| ABBVIE INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Abbott Laboratories | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: INGREZZA, NURTEC ODT, Ozempic, TRELEGY ELLIPTA, QULIPTA, MOUNJARO, Cologuard Collection Kit, BREZTRI.
Industry payments across IL — which companies pay providers there.
